Nicoventures was setup in 2010 by the British American Tobacco Company to develop and commercialize regulatory-approved, non-tobacco nicotine products. Nicoventures began a patent filing spree in 2019, filing 26 patent applications for nicotine-cannabinoid oral pouches and continuing the expansion of its patent portfolio in 2021. Nicoventures also owns patent applications for vape devices but is more focused on oral pouches.
| Loading Documents... |
